Xenon Pharmaceuticals Inc. · NASDAQ:XENE

Gannon Steven exercised options for 3,500 Xenon Pharmaceuticals Inc. shares (Form 4)

Traded May 12, 2026 · Filed May 13, 2026

On May 12, 2026, Gannon Steven (Director) exercised options for 3,500 Xenon Pharmaceuticals Inc. shares at US$7.38 for US$25,830, leaving 10,641 shares. Filed May 13, 2026 (Form 4).

Options exercised
3,500 shares
Price
US$7.38
Value
US$25,830
Holding after
10,641 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 12, 2026Common SharesOption exercise3,500US$7.3810,641Direct

Source

View original at SEC

Related